Live Breaking News & Updates on Mrna

Stay informed with the latest breaking news from Mrna on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Mrna and stay connected to the pulse of your community

Pioneering RNA vaccines could tackle all future virus mutations, eliminate need for booster doses

Viruses are formidable adversaries, possessing an uncanny ability to mutate into stronger forms each time one strain was defeated, necessitating new interventions

Proceedings-of-the-national-academy-sciences , National-academy , Virus , Vaccine , Universal-vaccine , Rnai , Rna , Mrna , Immune-response , Covid , Common-cold

Livforsakringsbolaget Skandia Omsesidigt Cuts Stock Position in Moderna, Inc. (NASDAQ:MRNA)

Livforsakringsbolaget Skandia Omsesidigt lessened its stake in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 84.1% during the 4th quarter, Holdings Channel.com reports. The firm owned 733 shares of the company’s stock after selling 3,867 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt’s holdings in Moderna were worth $73,000 as of its most recent SEC filing. Other […]

Canada , United-states , William-blair , Noubar-afeyan , Livforsakringsbolaget-skandia-omsesidigt , Holdings-channel , Royal-bank , Nasdaq , Invesco-ltd , Jefferies-financial-group , International-assets-investment-management , Canaccord-genuity-group

Daiwa Securities Group Inc. Has $4.86 Million Stock Position in Moderna, Inc. (NASDAQ:MRNA)

Daiwa Securities Group Inc. raised its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 5.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 48,900 shares of the company’s stock after purchasing an additional 2,476 shares during the quarter. Daiwa Securities Group […]

United-states , Canada , Stephen-hoge , William-blair , Morgan-stanley , Nasdaq , Daiwa-securities-group-inc , Royal-bank , Securities-exchange-commission , Manufacturers-life-insurance-company , Renaissance-technologies , Moderna-company-profile

Moderna (NASDAQ:MRNA) Receives Hold Rating from Needham & Company LLC

Needham & Company LLC restated their hold rating on shares of Moderna (NASDAQ:MRNA – Free Report) in a research note released on Thursday, Benzinga reports. Several other research analysts also recently weighed in on the company. William Blair reiterated a market perform rating on shares of Moderna in a report on Monday, April 1st. Canaccord […]

Canada , United-states , William-blair , Ogorek-anthony-joseph , Stephen-hoge , Group-wealth-management , Nasdaq , Canaccord-genuity-group , Stonebridge-capital-advisors , Arlington-trust-co , Moderna-inc , Needham-company

Hartford Investment Management Co. Reduces Stake in Moderna, Inc. (NASDAQ:MRNA)

Hartford Investment Management Co. lowered its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 0.9% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 22,360 shares of the company’s stock after selling 213 shares during the period. Hartford Investment Management Co.’s holdings in Moderna were worth $2,224,000 as of its most recent […]

Wellington , New-zealand-general- , New-zealand , Canada , United-states , Stephen-hoge , Securities-exchange-commission , Hartford-investment-management-co , Canaccord-genuity-group , Vanguard-group-inc , Nasdaq , Morgan-stanley

Moderna (NASDAQ:MRNA) Earns "Hold" Rating from Needham & Company LLC

Needham & Company LLC reaffirmed their hold rating on shares of Moderna (NASDAQ:MRNA – Free Report) in a research note issued to investors on Thursday, Benzinga reports. Other research analysts also recently issued research reports about the stock. Oppenheimer upgraded shares of Moderna from a market perform rating to an outperform rating and set a […]

United-states , Noubar-afeyan , Cetera-advisor-networks , Cim-investment-management-inc , Canaccord-genuity-group , Ancora-advisors , Jpmorgan-chase-co , Moderna-company-profile , Needham-company , Sunbelt-securities-inc , Securities-exchange-commission , Moderna-inc

Moderna (NASDAQ:MRNA) versus Cardiol Therapeutics (NASDAQ:CRDL) Head to Head Analysis

Moderna (NASDAQ:MRNA – Get Free Report) and Cardiol Therapeutics (NASDAQ:CRDL – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, valuation, dividends and profitability. Institutional and Insider Ownership 75.3% of Moderna shares are […]

Canada , Cambridge , Cambridgeshire , United-kingdom , Oakville , Ontario , Massachusetts , United-states , Chiesi-farmaceutici , Institute-for-life-changing-medicines , Cardiol-therapeutics-inc , Moderna-inc

Gene Therapy, DNA's Past, RNA's Future: A Time Of Promise

Gene therapy's history is filled with ingenuity, imagination, and exploration. The 1960s through the 1980s, in particular, were a time of significant progress.

France , Germany , West-germany , French , Richard-mulligan , Lorraine-kraus , Massachusetts-institute-of-technology , Development-of-gene-therapy-concepts , Gene-therapy , Massachusetts-institute , French-anderson , Promise-hits

Moderna receives a $750M infusion from Blackstone

Blackstone Life Sciences made an investment of up to $750 million in Moderna Inc.’s influenza program created with its mRNA technology. The new funding is designed to help propel the program forward and may help bolster a stock that has struggled in the past 12 months.

Blackstone-life-sciences , Moderna-inc , Moderna-inc- , Influenza , Mrna , Bioworld , Financings , Infection , Vaccine , Mrna-1283 , Covid-19

Itau Unibanco Holding S.A. Sells 326 Shares of Moderna, Inc. (NASDAQ:MRNA)

Itau Unibanco Holding S.A. cut its holdings in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 23.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,059 shares of the company’s stock after selling 326 shares during the quarter. […]

United-states , Canada , Arpa-garay , Stephen-hoge , Moderna-inc , Itau-unibanco-holding , Deutsche-bank-aktiengesellschaft , Wealth-strategies-group , Securities-exchange-commission , Canaccord-genuity-group , Group-wealth-management , Stonebridge-capital-advisors